文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血清白蛋白与肌酐比值在脓毒症预后评估中的作用

[Role of secrum albumin-to-creatinine ratio in assessing the prognosis of sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论回顾性队列显示sACR是脓毒症28天死亡的独立保护因素(HR=0.795),AUC 0.765,cut-off 2.446,可作为辅助预后标志物。

该回顾性队列纳入2023年10月至2024年10月安徽医科大学第四附属医院急诊ICU与综合ICU新诊断脓毒症患者177例(脓毒症66例、脓毒性休克111例;28天存活94例、死亡83例),收集入院24小时内WBC、CRP、PCT、白蛋白、肌酐并计算sACR,记录APACHE II与SOFA评分。结果显示存活者sACR高于死亡者[3.17(1.87,4.20) vs. 1.80(0.95,2.25)];Cox回归中sACR为独立保护因素(HR=0.795,95%CI 0.646-0.978,P=0.030),CRP、APACHE II、SOFA为独立危险因素。ROC分析sACR的AUC为0.765,最佳cut-off 2.446,敏感度66.0%、特异度77.1%;DeLong检验示sACR预测效能与SOFA相当、优于CRP、劣于APACHE II。提示sACR可作为脓毒症病情严重程度与预后评估的辅助生物标志物。

要点

  • 177例新诊断脓毒症患者中,28天存活者sACR高于死亡者[3.17(1.87,4.20) vs. 1.80(0.95,2.25)],差异有统计学意义(P<0.05)。
  • Cox回归示sACR为28天全因死亡的独立保护因素(HR=0.795,95%CI 0.646-0.978,P=0.030),CRP、APACHE II、SOFA为独立危险因素。
  • sACR预测28天预后AUC 0.765,最佳cut-off 2.446,敏感度66.0%、特异度77.1%。
  • DeLong检验示sACR预测效能与SOFA评分相当,优于CRP,但劣于APACHE II评分。
  • 脓毒症组sACR高于脓毒性休克组[2.98(1.82,4.10) vs. 2.26(1.19,3.08)],提示sACR与病情严重程度相关。

适用人群与场景

  • 2023年10月至2024年10月安徽医科大学第四附属医院急诊ICU与综合ICU收治的新诊断脓毒症患者,共177例(脓毒症66例、脓毒性休克111例)。

诊断标准与关键阈值

  • 按脓毒症严重程度分为脓毒症组与脓毒性休克组;按28天结局分为存活组与死亡组。
  • sACR由入院24小时内血清白蛋白与肌酐计算;预测28天预后的最佳cut-off为2.446,敏感度66.0%、特异度77.1%。
  • 记录入院时APACHE II评分与SOFA评分;原文未提及具体的评分界值或启动/停止阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及需要立刻处理或不能漏诊的具体红旗征及处理措施。

研究设计与关键结果

  • 研究类型:单中心回顾性队列研究;样本量177例(脓毒症66例、脓毒性休克111例;28天存活94例、死亡83例);中心数:1个(安徽医科大学第四附属医院急诊ICU与综合ICU)。
  • 人群:新诊断脓毒症患者;干预/对照:无干预,按严重程度及28天结局分组比较基线资料与实验室指标。
  • 主要终点结果:sACR为28天全因死亡的独立保护因素(HR=0.795,95%CI 0.646-0.978,P=0.030);CRP(HR=1.004,95%CI 1.001-1.007,P=0.043)、APACHE II(HR=1.078,95%CI 1.049-1.108,P<0.001)、SOFA(HR=1.105,95%CI 1.027-1.189,P=0.008)为独立危险因素。
  • 关键次要终点:sACR预测28天预后的AUC为0.765,最佳cut-off 2.446,敏感度66.0%、特异度77.1%;DeLong检验示sACR预测效能与SOFA相当、优于CRP、劣于APACHE II。
  • 组间比较:脓毒症组sACR高于脓毒性休克组[2.98(1.82,4.10) vs. 2.26(1.19,3.08)];存活组sACR高于死亡组[3.17(1.87,4.20) vs. 1.80(0.95,2.25)],均P<0.05。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究;原文未给出证据等级或推荐强度。
  • 局限:单中心、回顾性设计、样本量177例;原文未提及盲法、失访或外部验证情况。

对床旁实践的改变

  • sACR可作为脓毒症患者入院24小时内评估病情严重程度与28天预后的辅助生物标志物,但不能替代APACHE II评分(后者预测效能更优)。
  • sACR最佳cut-off 2.446来自单中心回顾性研究,需前瞻性外部验证后才能作为床旁决策阈值;不应据此单独决定治疗强度。
  • 原文未提及sACR对治疗决策或液体复苏、血管活性药物使用的指导作用,临床不应据此改变现有脓毒症集束化治疗流程。

指南或共识出处

  • 原文未提及指南或共识出处;文献来源为Zhonghua Wei Zhong Bing Ji Jiu Yi Xue。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the role of serum albumin-to-creatinine ratio (sACR) in prognostic assessment of patients with sepsis.

METHODS: A retrospective cohort study was conducted. Patients with newly diagnosed sepsis admitted to the emergency intensive care unit (ICU) and comprehensive ICU of the Fourth Affiliated Hospital of Anhui Medical University from October 2023 to October 2024 were enrolled. Baseline data and laboratory parameters within 24 hours of admission, including white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), serum albumin, and creatinine, were collected, and sACR was calculated. The Acute Physiology and Chronic Health Evaluation II(APACHE II) and Sequential Organ Failure Assessment (SOFA) were recorded at admission. The 28-day survival status and survival time were documented. Patients were divided into sepsis group and septic shock group according to sepsis severity, and further divided into survivor group and non-survivor group based on 28-day outcomes. The above parameters were compared between groups. Cox proportional hazards regression analysis was used to identify independent prognostic factors for 28-day mortality. Receiver operator characteristic curves (ROC curves) were plotted to evaluate the predictive value of each indicator, and the areas under the curves (AUCs) were compared using DeLong's test.

RESULTS: A total of 177 patients with newly diagnosed sepsis were included, comprising 66 in the sepsis group and 111 in the septic shock group; 94 survived and 83 died within 28 days. Significant differences were observed between the sepsis and septic shock groups in age, WBC, CRP, PCT, APACHE II score, SOFA score, and sACR (all P<0.05), with sACR being higher in the sepsis group [2.98 (1.82, 4.10) vs. 2.26 (1.19, 3.08)]. Significant differences were also found between survivors and non-survivors in WBC, CRP, PCT, APACHE II score, SOFA score, and sACR (all P<0.05), with sACR being higher in survivors [3.17 (1.87, 4.20) vs. 1.80 (0.95, 2.25)]. Cox regression analysis showed that CRP (HR=1.004, 95%CI was 1.001-1.007, P=0.043), APACHE II score (HR=1.078, 95%CI was 1.049-1.108, P<0.001), and SOFA score (HR=1.105, 95%CI was 1.027-1.189, P=0.008) were independent risk factors for 28-day all-cause mortality, while sACR was an independent protective factor (HR=0.795, 95%CI was 0.646-0.978, P=0.030). ROC curve analysis revealed that CRP, APACHE II score, SOFA score, and sACR had certain predictive value for 28-day prognosis; the AUC of sACR was 0.765, with an optimal cut-off value of 2.446, yielding a sensitivity of 66.0% and specificity of 77.1%. DeLong's test indicated that the predictive performance of sACR was similar to that of SOFA score, superior to CRP, but inferior to APACHE II score.

CONCLUSIONS: As a novel composite biomarker, sACR has potential adjunctive value in assessing disease severity and predicting prognosis in patients with sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Bao Z, Li P, Zhang L, et al. [Role of secrum albumin-to-creatinine ratio in assessing the prognosis of sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42875238. doi:10.3760/cma.j.cn121430-20260318-00127

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。